Skip to main content
. 2006 Jan 23;147(6):587–595. doi: 10.1038/sj.bjp.0706669

Table 3.

Selected pharmacologic parameters following 4 weeks of daily formoterol or salmeterol administration (n=8 rats dose−1)

  Formoterol Salmeterol
EDL    
Emax (% control) 130.2±2.1 142.7±3.1*
Log ED50 (mM kg−1 day−1) −5.8±0.3 −3.7±0.9*
ED50 (μg kg−1 day−1) (0.3⩽1⩽6) (63⩽130⩽253)*
     
Soleus    
Emax (% control) 119.1±4.4 130.7±4.1*
Log ED50 (mM kg−1 day−1) −6.1±0.9 −3.9±0.3
ED50 (μg kg−1 day−1) (0.003⩽0.7⩽167) (16⩽74⩽337)
     
Heart    
Emax (% control) 125.4±3.2 120.3±2.9
Log ED50 (mM kg−1 day−1) −4.9±0.3 −4.0±0.3
ED50 (μg kg−1 day−1) (0.2⩽11⩽69) (9⩽59⩽401)

CI: confidence interval, EDL: extensor digitorum longus, ED50: drug concentration at half of the maximum effect, Emax: maximum hypertrophic effect.

*

P<0.05 formoterol vs salmeterol.

Note that ED50 values are presented as 95% CI.